272 related articles for article (PubMed ID: 32056720)
21. Lung Deposition and Inspiratory Flow Rate in Patients with Chronic Obstructive Pulmonary Disease Using Different Inhalation Devices: A Systematic Literature Review and Expert Opinion.
Baloira A; Abad A; Fuster A; García Rivero JL; García-Sidro P; Márquez-Martín E; Palop M; Soler N; Velasco JL; González-Torralba F
Int J Chron Obstruct Pulmon Dis; 2021; 16():1021-1033. PubMed ID: 33907390
[TBL] [Abstract][Full Text] [Related]
22. Effect of Disease Severity in Asthma and Chronic Obstructive Pulmonary Disease on Inhaler-Specific Inhalation Profiles Through the ELLIPTA® Dry Powder Inhaler.
Prime D; de Backer W; Hamilton M; Cahn A; Preece A; Kelleher D; Baines A; Moore A; Brealey N; Moynihan J
J Aerosol Med Pulm Drug Deliv; 2015 Dec; 28(6):486-97. PubMed ID: 26372467
[TBL] [Abstract][Full Text] [Related]
23. The importance of inhaler devices: the choice of inhaler device may lead to suboptimal adherence in COPD patients.
Darbà J; Ramírez G; Sicras A; Francoli P; Torvinen S; Sánchez-de la Rosa R
Int J Chron Obstruct Pulmon Dis; 2015; 10():2335-45. PubMed ID: 26604733
[TBL] [Abstract][Full Text] [Related]
24. Inspiratory flow profile and usability of the NEXThaler, a multidose dry powder inhaler, in asthma and COPD.
Chetta A; Yorgancioglu A; Scuri M; Barile S; Guastalla D; Dekhuijzen PNR
BMC Pulm Med; 2021 Feb; 21(1):65. PubMed ID: 33632183
[TBL] [Abstract][Full Text] [Related]
25. The clinical relevance of dry powder inhaler performance for drug delivery.
Demoly P; Hagedoorn P; de Boer AH; Frijlink HW
Respir Med; 2014 Aug; 108(8):1195-203. PubMed ID: 24929253
[TBL] [Abstract][Full Text] [Related]
26. Inhaler device selection: special considerations in elderly patients with chronic obstructive pulmonary disease.
Barrons R; Pegram A; Borries A
Am J Health Syst Pharm; 2011 Jul; 68(13):1221-32. PubMed ID: 21690428
[TBL] [Abstract][Full Text] [Related]
27. Inspiratory flow rates at different levels of resistance in elderly COPD patients.
Janssens W; VandenBrande P; Hardeman E; De Langhe E; Philps T; Troosters T; Decramer M
Eur Respir J; 2008 Jan; 31(1):78-83. PubMed ID: 17898020
[TBL] [Abstract][Full Text] [Related]
28. Which factors affect the choice of the inhaler in chronic obstructive respiratory diseases?
Scichilone N; Benfante A; Bocchino M; Braido F; Paggiaro P; Papi A; Santus P; Sanduzzi A
Pulm Pharmacol Ther; 2015 Apr; 31():63-7. PubMed ID: 25724817
[TBL] [Abstract][Full Text] [Related]
29. Nebulized Therapies in COPD: Past, Present, and the Future.
Barjaktarevic IZ; Milstone AP
Int J Chron Obstruct Pulmon Dis; 2020; 15():1665-1677. PubMed ID: 32764912
[TBL] [Abstract][Full Text] [Related]
30. From the infant to the geriatric patient-Strategies for inhalation therapy in asthma and chronic obstructive pulmonary disease.
Hagmeyer L; van Koningsbruggen-Rietschel S; Matthes S; Rietschel E; Randerath W
Clin Respir J; 2023 Jun; 17(6):487-498. PubMed ID: 37054701
[TBL] [Abstract][Full Text] [Related]
31. In Vitro Dosing Performance of the ELLIPTA® Dry Powder Inhaler Using Asthma and COPD Patient Inhalation Profiles Replicated with the Electronic Lung (eLung™).
Hamilton M; Leggett R; Pang C; Charles S; Gillett B; Prime D
J Aerosol Med Pulm Drug Deliv; 2015 Dec; 28(6):498-506. PubMed ID: 26372465
[TBL] [Abstract][Full Text] [Related]
32. Use of pressurized metered dose inhalers in patients with chronic obstructive pulmonary disease: review of evidence.
Aggarwal B; Gogtay J
Expert Rev Respir Med; 2014 Jun; 8(3):349-56. PubMed ID: 24802511
[TBL] [Abstract][Full Text] [Related]
33. The relationship between peak inspiratory flow and hand grip strength measurement in men with mild chronic obstructive pulmonary disease.
Tsuburai T; Komase Y; Tsuruoka H; Oyama B; Muraoka H; Hida N; Kobayashi T; Matsushima S
BMC Pulm Med; 2022 Feb; 22(1):65. PubMed ID: 35177056
[TBL] [Abstract][Full Text] [Related]
34. Misuse and/or treatment delivery failure of inhalers among patients with asthma or COPD: A review and recommendations for the conduct of future research.
Mahon J; Fitzgerald A; Glanville J; Dekhuijzen R; Glatte J; Glanemann S; Torvinen S
Respir Med; 2017 Aug; 129():98-116. PubMed ID: 28732842
[TBL] [Abstract][Full Text] [Related]
35. Inhaled therapy in elderly COPD patients; time for re-evaluation?
Jarvis S; Ind PW; Shiner RJ
Age Ageing; 2007 Mar; 36(2):213-8. PubMed ID: 17267450
[TBL] [Abstract][Full Text] [Related]
36. The Role of Inspiratory Pressures in Determining the Flow Rates Though Dry Powder Inhalers; A Review.
Clark AR
Curr Pharm Des; 2015; 21(27):3974-83. PubMed ID: 26290203
[TBL] [Abstract][Full Text] [Related]
37. Asthma and chronic obstructive pulmonary disease inhalers: Techniques for proper use.
Pepper AN; Cooke A; Livingston L; Lockey RF
Allergy Asthma Proc; 2016 Jul; 37(4):279-90. PubMed ID: 27401315
[TBL] [Abstract][Full Text] [Related]
38. Nanotechnology-Assisted Metered-Dose Inhalers (MDIs) for High-Performance Pulmonary Drug Delivery Applications.
Kumar R; Mehta P; Shankar KR; Rajora MAK; Mishra YK; Mostafavi E; Kaushik A
Pharm Res; 2022 Nov; 39(11):2831-2855. PubMed ID: 35552983
[TBL] [Abstract][Full Text] [Related]
39. A systematic review of comparative studies of tiotropium Respimat® and tiotropium HandiHaler® in patients with chronic obstructive pulmonary disease: does inhaler choice matter?
Dahl R; Kaplan A
BMC Pulm Med; 2016 Oct; 16(1):135. PubMed ID: 27724909
[TBL] [Abstract][Full Text] [Related]
40. Inspiratory muscle training may increase peak inspiratory flow in chronic obstructive pulmonary disease.
Weiner P; Weiner M
Respiration; 2006; 73(2):151-6. PubMed ID: 16155355
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
